Company Reaffirms Commitment to Safety, Innovation, and Patient Trust
PALM HARBOR, Fla., July 1, 2025 /PRNewswire/ — Regener-Eyes®, a leader in eye drops to relieve dryness of the eye, is pleased to announce that the U.S. Food and Drug Administration (FDA) has officially closed the voluntary product recall, marking full recall regulatory resolution and a return to normal operations.
“By proactively initiating this voluntary recall, we took an already safe product and made it even safer,” said a company spokesperson. “This outcome reinforces patient and provider trust and our commitment to delivering the highest standards of safety and quality.”
The recall was initiated out of an abundance of caution and reflects Regener-Eyes®’ unwavering dedication to patient safety. After a comprehensive review, the company identified a potential concern and introduced an enhanced bottle design featuring advanced backflow prevention technology to help protect against microbial contamination. This improvement further safeguards product integrity and demonstrates Regener-Eyes®’ commitment to continuous improvement in both safety and manufacturing processes.
Regener-Eyes® is in full production and distribution of its upgraded bottle and remains confident in its continued safety and efficacy. Regener-Eyes® remains dedicated to transparent communication with healthcare providers, patients, and regulators as it reaffirms the mission to deliver innovative solutions for ocular health.
For additional information, please visit regenereyes.com.
Email: [email protected]
Phone: 877-260-0706
SOURCE Regener-Eyes
WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+Newsrooms &Influencers
9k+Digital MediaOutlets
270k+JournalistsOpted In